About
Co-founder of 4DMT; CEO and director since the company's inception in 2013 and President since January 2026. Former Executive Chairman until August 2020. Adjunct Professor of Bioengineering and Molecular & Cellular Biology at U.C. Berkeley and co-founder of the U.C. Berkeley Life Sciences Entrepreneurship Center. Previously co-founder and Executive Chairman of Ignite Immunotherapy and held senior development roles at Onyx Pharmaceuticals and Celgene.
Roles
4D Molecular Therapeutics, Inc.
Co-Founder, President, Chief Executive Officer and Director · Current role
2013–present
Fixed Compensation
FY 2025Salary
$667,252
ComponentAnnual base salary
All other compensation
$744
Total compensation
$2,051,343
Performance Compensation
Data from FY 2025Cash incentive
Annual cash incentive
$560,597
FormNon-Equity Incentive Plan Compensation
Stock awards
Option awards
$822,750
FormStock options
Also at 4D Molecular Therapeutics, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.